NFKB1 and acute myeloid leukemia: HDAC inhibition has also previously been demonstrated to signal pro-survival pathway feedback in the form of hyperacetylation of p65 NFκB signalling [37]; dual inhibition of HDAC and NFκB may potentiate efficacy in AML [38].